Medmain Inc. Secures Patent for AI System Enhancing Pathology Report Creation Efficiency Medmain Inc. has successfully obtained a patent for an AI-driven system designed to streamline the creation of pathology reports, significantly enhancing diagnostic accuracy and reducing workload.

Medmain Inc. Secures Patent for AI System Enhancing Pathology Report Creation Efficiency #Japan #AI_in_Healthcare #Fukuoka #Medmain #Pathology_Reports

Medmain's PidPort Cloud System Begins Trials at Vietnam's Ha Dong General Hospital Medmain's digital pathology AI system, PidPort, has started its trials at Ha Dong General Hospital in Hanoi, Vietnam, enhancing diagnostic accuracy.

Medmain's PidPort Cloud System Begins Trials at Vietnam's Ha Dong General Hospital #Vietnam #Hanoi #AI_Pathology #Medmain #PidPort

Medmain and SMC Form Strategic Partnership for AI Pathology in Vietnam Medmain Inc. and SMC Medical Tourism Japan have signed a partnership to promote AI-driven pathology diagnostics in Vietnam, enhancing medical cooperation.

Medmain and SMC Form Strategic Partnership for AI Pathology in Vietnam #Japan #Fukuoka #SMC #AI_Pathology #Medmain

Medmain Partners with Vietnamese Hospitals to Enhance Digital Pathology and AI in Healthcare Medmain, a leading tech company, has signed an MOU with various Vietnamese hospitals to implement AI-driven digital pathology solutions, aiming to revolutionize healthcare.

Medmain Partners with Vietnamese Hospitals to Enhance Digital Pathology and AI in Healthcare #Japan #AI #Vietnam #Fukuoka #Medmain

Medmain Secures $3.3M to Expand AI-Powered Digital Pathology Solutions Medmain, a Japanese AI pathology startup, has successfully raised $3.3M to enhance its digital pathology services and expand internationally amid increasing demand.

Medmain Secures $3.3M to Expand AI-Powered Digital Pathology Solutions #Japan #AI_Technology #Fukuoka #Medmain #PidPort

Medmain Raises $4.7 Million to Strengthen Digital Pathology AI Development and Expansion Medmain has successfully raised ¥470 million, bringing its total funding to ¥2.5 billion, aiming to enhance its pathology AI platform and global outreach.

Medmain Raises $4.7 Million to Strengthen Digital Pathology AI Development and Expansion #Japan #Fukuoka #Medmain #PidPort #One_Capital